Characterization of platelet aggregation in whole blood of laboratory animals by a screen filtration pressure method

References

• Born G V R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927–9.
   PubMed Web of Science ®Google Scholar
• Cardinal D C, Flower R J. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3: 135–58.
   PubMedGoogle Scholar
• Kundu S K, Heilmann E J, Sio R, Garcia C, Davidson R M, Ostgaard R A. Description of an in vitro platelet function analyzer PFA-100. Semin Thromb Hemost 1995; 21 (Suppl 2): 106–12.
   Google Scholar
• Ozeki Y, Sudo T, Toga K, Nagamura Y, Ito H, Ogawa T, Kimura Y. Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method. Thromb Res 2001; 101: 65–72.
   PubMed Web of Science ®Google Scholar
• Swank R L. Alteration of blood on storage: measurement of adhesiveness of ‘aging’ platelets and leukocytes and their removal by filtration. New Engl J Med 1961; 265: 728–33.
   PubMed Web of Science ®Google Scholar
• Swank R L, Roth J G, Jansen J. Screen filtration pressure method and adhesiveness and aggregation of blood cells. J Appl Physiol 1964; 19: 340–6.
   PubMed Web of Science ®Google Scholar
• Dhall D P, Engeset J, McKenzie F N, Matheson N A. Screen filtration pressure of blood – an evaluation. Cardiovasc Res 1969; 3: 147–54.
   PubMed Web of Science ®Google Scholar
• Dhall D P, Matheson N A. Platelet aggregate filtration pressure – a method of measuring platelet aggregation in whole blood. Cardiovasc Res 1969; 3: 155–60.
   PubMed Web of Science ®Google Scholar
• Sudo T, Ito H, Ozeki Y, Kimura Y. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method. Br J Pharmacol 2001; 133: 1396–404.
   PubMed Web of Science ®Google Scholar
• Qi R, Yatomi Y, Ozaki Y. Effects of incubation time, temperature, and anticoagulants on platelet aggregation in whole blood. Thromb Res 2001; 101: 139–44.
   PubMed Web of Science ®Google Scholar
• Rile G, Yatomi Y, Qi R, Satoh K, Ozaki Y. Potentiation of ibudilast inhibition of platelet aggregation in the presence of endothelial cells. Thromb Res 2001; 102: 239–46.
   PubMed Web of Science ®Google Scholar
• Kunishima T, Musha H, Aoyagi H, Kongohji K, Imai Y, Ozawa A, Soh T, Murayama M. Evaluation of the efficacy of antiplatelet drugs for ischemic heart disease patients. Jpn Circ J 2001; 65 (Suppl. 1A): 259.
   Google Scholar
• Inoue T, Hayashi M, Uchida T, Takayanagi K, Hayashi T, Morooka S. Significance of platelet aggregability immediately after blood sampling and effect of cigarette smoking. Platelets 2001; 12: 415–8.
   PubMed Web of Science ®Google Scholar
• Kondoh R, Konno S, Koizumi D, Mizuno M. Effects of anti- platelet agents on platelet aggregability determined by a screen filtration pressure method with a new type of whole blood aggregometer. Jpn J Stroke 2001; 23: 307–15.
   Google Scholar
• Kimura Y, Tani T, Kanbe T, Watanabe K. Effect of cilostazol on platelet aggregation and experimental thrombosis. Arzneim Forsch 1985; 35: 1144–9.
   PubMed Web of Science ®Google Scholar
• Sudo T, Tachibana K, Toga K, Tochizawa S, Inoue Y, Kimura Y, Hidaka H. Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity. Biochem Pharmacol 2000; 59: 347–56.
   PubMed Web of Science ®Google Scholar
• Mase K, Yanagihara F, Asada T, Yamanaka Y, Yoshioka M, Yasunaga K. Evaluation of platelet aggregation test by grading curve. Rinsho Byori 1992; 40: 857–62.
   PubMedGoogle Scholar
• Imiya M, Matsuo T. A new parameter for evaluating platelet aggregation in patients with chronic cerebral infarction. Rinsho Byori 1993; 41: 923–9.
   PubMedGoogle Scholar
• Kurata M, Ishizuka N, Matsuzawa M, Haruta K, Takeda K. A comparative study of whole-blood platelet aggregation in laboratory animals: its species differences and comparison with turbidimetric method. Comp Biochem Physiol 1995; 112C: 359–65.
   Google Scholar
• Cook N S, Zerwes H, Tapparelli C, Powling M, Singh J, Metternich R, Hagenbach A. Platelet aggregation and fibrino- gen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists. Thromb Haemost 1993; 70: 531–9.
   PubMed Web of Science ®Google Scholar
• Riess H, Braun G, Brehm G, Hiller E. Critical evaluation of platelet aggregation in whole human blood. Am J Clin Pathol 1986; 85: 50–6.
   PubMed Web of Science ®Google Scholar
• Taylor R R, Strophair J, Sturm M, Vandongen R, Beilin L J. Time dependence of whole blood aggregation in response to platelet activating factor (PAF). Thromb Haemost 1988; 59: 162–3.
   PubMed Web of Science ®Google Scholar
• Santos M T, Valle´ s J, Aznar J, Pe´ rez-Requejo J L. Role of red blood cells in the early stages of platelet activation by collagen. Thromb Haemost 1986; 56: 376–81.
   PubMed Web of Science ®Google Scholar
• Setiabudy-Dharma R, Funahara Y. Enhancement of collagen- induced aggregation of platelets in whole blood. Thromb Res 1986; 42: 621–34.
   PubMed Web of Science ®Google Scholar
• Valle´s J, Santos M T, Aznar J, Martı´nez M, Moscardo´ A, Pin˜o´n M, Broekman M J, Marcus A J. Platelet-erythrocyte interactions enhance aIIbb3 integrin receptor activation and P-selectin expression during platelet recruitment: down-regula- tion by aspirin ex vivo. Blood 2002; 99: 3978–84.
   PubMed Web of Science ®Google Scholar
• Abbate R, Favilla S, Boddi M, Costanzo G, Prisco D. Factors influencing platelet aggregation in whole blood. Am J Clin Pathol 1986; 86: 91–6.
   PubMed Web of Science ®Google Scholar